Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) — Net Asset Quality Index
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) has a Net Asset Quality Index of 72.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €10.44 Billion minus total liabilities of €2.91 Billion yields net assets of €7.52 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 2TZ cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited Net Asset Quality Index Over Time (2013–2025)
This chart shows how Tianjin Zhong Xin Pharmaceutical Group Corporation Limited's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 72.1%, representing net assets of €7.52 Billion against total assets of €10.44 Billion EUR. See working capital position of Tianjin Zhong Xin Pharmaceutical Group C to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Tianjin Zhong Xin Pharmaceutical Group Corporation Limited from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 2TZ company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 60.7% | €7.10 Billion | €11.69 Billion | €4.59 Billion | ▼ -12.2 pp |
| 2024 | 72.9% | €7.85 Billion | €10.77 Billion | €2.92 Billion | ▲ +7.9 pp |
| 2023 | 65.0% | €6.65 Billion | €10.23 Billion | €3.58 Billion | ▲ +0.5 pp |
| 2022 | 64.5% | €6.55 Billion | €10.16 Billion | €3.61 Billion | ▼ -7.3 pp |
| 2021 | 71.8% | €6.51 Billion | €9.07 Billion | €2.55 Billion | ▲ +0.0 pp |
| 2020 | 71.8% | €5.95 Billion | €8.28 Billion | €2.33 Billion | ▲ +1.4 pp |
| 2019 | 70.4% | €5.52 Billion | €7.84 Billion | €2.32 Billion | ▼ -0.7 pp |
| 2018 | 71.1% | €5.05 Billion | €7.11 Billion | €2.05 Billion | ▲ +1.3 pp |
| 2017 | 69.9% | €4.63 Billion | €6.62 Billion | €2.00 Billion | ▲ +2.2 pp |
| 2016 | 67.6% | €4.30 Billion | €6.36 Billion | €2.06 Billion | ▼ 0.0 pp |
| 2015 | 67.6% | €4.11 Billion | €6.07 Billion | €1.96 Billion | ▲ +13.4 pp |
| 2014 | 54.2% | €2.95 Billion | €5.44 Billion | €2.49 Billion | ▲ +5.3 pp |
| 2013 | 48.9% | €2.57 Billion | €5.26 Billion | €2.69 Billion | — |